Skin Cancer

Topical Immunosuppressants Drugs Don’t Increase Risk of Common Skin Cancers, Despite Warning Labels
October 05, 2020

A study published in JAMA Dermatology determined that topical immunosuppressant medications used to treat adult patients with atopic dermatitis do not increase the risk of common forms of cancer despite warning labels on the packaging.

PD-1 antibody Induces Clinical Activity in Patients with Locally Advanced Basal Cell Carcinoma
September 18, 2020

Cemiplimab demonstrated an objective response rate of 31% in patients with locally advanced basal cell carcinoma who progress on or are intolerant to hedgehog inhibitors.

Personalized Cancer Vaccine Shows Long-Term Survival for Patients with High-Risk Melanoma
August 06, 2020

Data released from a phase 2b clinical trial showed statistically significant long-term survival for patients with stage III or IV melanoma at high-risk of recurrence.